211 related articles for article (PubMed ID: 8434558)
1. Glycation and oxidation: a role in the pathogenesis of atherosclerosis.
Lyons TJ
Am J Cardiol; 1993 Feb; 71(6):26B-31B. PubMed ID: 8434558
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein glycation and its metabolic consequences.
Lyons TJ
Diabetes; 1992 Oct; 41 Suppl 2():67-73. PubMed ID: 1526339
[TBL] [Abstract][Full Text] [Related]
3. Glycation and glycoxidation of low-density lipoproteins by glucose and low-molecular mass aldehydes. Formation of modified and oxidized particles.
Knott HM; Brown BE; Davies MJ; Dean RT
Eur J Biochem; 2003 Sep; 270(17):3572-82. PubMed ID: 12919321
[TBL] [Abstract][Full Text] [Related]
4. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
Calvo C
Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques.
Imanaga Y; Sakata N; Takebayashi S; Matsunaga A; Sasaki J; Arakawa K; Nagai R; Horiuchi S; Itabe H; Takano T
Atherosclerosis; 2000 Jun; 150(2):343-55. PubMed ID: 10856526
[TBL] [Abstract][Full Text] [Related]
6. Glucose oxidation and low-density lipoprotein-induced macrophage ceroid accumulation: possible implications for diabetic atherosclerosis.
Hunt JV; Bottoms MA; Clare K; Skamarauskas JT; Mitchinson MJ
Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):243-9. PubMed ID: 8198540
[TBL] [Abstract][Full Text] [Related]
7. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
Sakata N; Uesugi N; Takebayashi S; Nagai R; Jono T; Horiuchi S; Takeya M; Itabe H; Takano T; Myint T; Taniguchi N
Cardiovasc Res; 2001 Feb; 49(2):466-75. PubMed ID: 11164857
[TBL] [Abstract][Full Text] [Related]
8. Glucosylated glycerophosphoethanolamines are the major LDL glycation products and increase LDL susceptibility to oxidation: evidence of their presence in atherosclerotic lesions.
Ravandi A; Kuksis A; Shaikh NA
Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):467-77. PubMed ID: 10669645
[TBL] [Abstract][Full Text] [Related]
9. Why is glycated LDL more sensitive to oxidation than native LDL? A comparative study.
Sobal G; Menzel J; Sinzinger H
Prostaglandins Leukot Essent Fatty Acids; 2000 Oct; 63(4):177-86. PubMed ID: 11049692
[TBL] [Abstract][Full Text] [Related]
10. Glycation as an atherogenic modification of LDL.
Younis N; Sharma R; Soran H; Charlton-Menys V; Elseweidy M; Durrington PN
Curr Opin Lipidol; 2008 Aug; 19(4):378-84. PubMed ID: 18607185
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway.
Kawamura M; Heinecke JW; Chait A
J Clin Invest; 1994 Aug; 94(2):771-8. PubMed ID: 8040332
[TBL] [Abstract][Full Text] [Related]
12. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Aviram M
Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
[TBL] [Abstract][Full Text] [Related]
13. [Lipoprotein glycation and glycoxidation: their importance in diabetes mellitus].
Actis Dato SM; Rebolledo OR
Medicina (B Aires); 2000; 60(5 Pt 1):645-56. PubMed ID: 11188909
[TBL] [Abstract][Full Text] [Related]
14. Role of nonenzymatic glycosylation in atherogenesis.
Cerami A; Vlassara H; Brownlee M
J Cell Biochem; 1986; 30(2):111-20. PubMed ID: 3517022
[TBL] [Abstract][Full Text] [Related]
15. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
Takeuchi N; Saheki S
Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
[TBL] [Abstract][Full Text] [Related]
16. Nonenzymatic glycosylation products on collagen covalently trap low-density lipoprotein.
Brownlee M; Vlassara H; Cerami A
Diabetes; 1985 Sep; 34(9):938-41. PubMed ID: 4029512
[TBL] [Abstract][Full Text] [Related]
17. A comparative study of cultured smooth muscle cell proliferation and injury, utilizing glycated low density lipoproteins with slight oxidation, auto-oxidation, or extensive oxidation.
Taguchi S; Oinuma T; Yamada T
J Atheroscler Thromb; 2000; 7(3):132-7. PubMed ID: 11480453
[TBL] [Abstract][Full Text] [Related]
18. Calcium antagonists as inhibitors of in vitro low density lipoprotein oxidation and glycation.
Sobal G; Menzel EJ; Sinzinger H
Biochem Pharmacol; 2001 Feb; 61(3):373-9. PubMed ID: 11172743
[TBL] [Abstract][Full Text] [Related]
19. The role of oxidized low-density lipoproteins in the pathogenesis of atherosclerosis.
Parthasarathy S; Steinberg D; Witztum JL
Annu Rev Med; 1992; 43():219-25. PubMed ID: 1580586
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of LDL and its subfractions to glycation.
Soran H; Durrington PN
Curr Opin Lipidol; 2011 Aug; 22(4):254-61. PubMed ID: 21734572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
